Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03298412 |
|---|---|
| Brief Title: | Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT) |
| First Submitted : | September 12, 2017 |
| First Submitted that Met QC Criteria : | September 26, 2017 |
| First Posted : | October 2, 2017 |
| Results First Submitted : | August 20, 2020 |
| Results First Posted with QC Comments : | September 3, 2020 |
| Results First Submitted that Met QC Criteria : | September 10, 2020 |
| Results First Posted : | September 11, 2020 |
| Last Update Submitted that Met QC Criteria : | September 10, 2020 |
| Last Update Posted : | September 11, 2020 |